Curbstone Financial Management Corp Bristol Myers Squibb CO Transaction History

Curbstone Financial Management Corp

$451 Million
Q2 2024

A detailed history of Curbstone Financial Management Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Curbstone Financial Management Corp holds 19,790 shares of BMY stock, worth $843,845. This represents 0.18% of its overall portfolio holdings.

Number of Shares

19,790

Previous 21,360 7.35%

Holding current value

$843,845

Previous $1.16 Million 29.1%

% of portfolio

0.18%

Previous 0.26%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 03, 2024	SELL	$40.25 - $52.99 $63,192 - $83,194	-1,570 Reduced 7.35%	19,790 $821,000
Q1 2024 Apr 09, 2024	BUY	$47.98 - $54.4 $12,474 - $14,144	260 Added 1.23%	21,360 $1.16 Million
Q4 2023 Jan 08, 2024	SELL	$48.48 - $57.85 $1,745 - $2,082	-36 Reduced 0.17%	21,100 $1.08 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $3,285 - $3,726	50 Added 0.24%	21,136 $1.46 Million
Q4 2022 Jan 19, 2023	SELL	$68.48 - $81.09 $145,314 - $172,072	-2,122 Reduced 9.14%	21,086 $1.52 Million

Q3 2022 Oct 05, 2022	BUY	$0.13 - $76.84 $221 - $130,628	1,700 Added 7.9%	23,208 $1.65 Million
Q2 2022 Aug 04, 2022	SELL	$72.62 - $79.98 $12,781 - $14,076	-176 Reduced 0.81%	21,508 $1.66 Million
Q1 2022 Apr 18, 2022	BUY	$61.48 - $73.72 $12,296 - $14,744	200 Added 0.93%	21,684 $1.58 Million
Q4 2021 Jan 19, 2022	BUY	$53.63 - $62.52 $96,534 - $112,536	1,800 Added 9.14%	21,484 $1.34 Million
Q3 2021 Oct 06, 2021	SELL	$59.17 - $69.31 $14,437 - $16,911	-244 Reduced 1.22%	19,684 $1.17 Million
Q2 2021 Jul 09, 2021	SELL	$61.91 - $67.42 $6,191 - $6,742	-100 Reduced 0.5%	19,928 $1.33 Million
Q1 2021 Apr 05, 2021	SELL	$59.34 - $66.74 $6,527 - $7,341	-110 Reduced 0.55%	20,028 $1.26 Million
Q4 2020 Jan 14, 2021	SELL	$57.74 - $65.43 $34,644 - $39,258	-600 Reduced 2.89%	20,138 $1.25 Million
Q3 2020 Oct 02, 2020	BUY	$57.43 - $63.64 $30,782 - $34,111	536 Added 2.65%	20,738 $1.25 Million
Q1 2020 Apr 20, 2020	SELL	$46.4 - $67.43 $22,828 - $33,175	-492 Reduced 2.38%	20,202 $1.13 Million
Q4 2019 Jan 10, 2020	BUY	$49.21 - $64.19 $54,623 - $71,250	1,110 Added 5.67%	20,694 $1.33 Million
Q3 2019 Oct 18, 2019	BUY	$42.77 - $50.71 $21,385 - $25,355	500 Added 2.62%	19,584 $993,000
Q2 2019 Jul 09, 2019	BUY	$44.62 - $49.34 $209,357 - $231,503	4,692 Added 32.6%	19,084 $865,000
Q1 2019 Apr 10, 2019	BUY	$45.12 - $53.8 $83,472 - $99,530	1,850 Added 14.75%	14,392 $687,000
Q4 2018 Jan 09, 2019	BUY	$48.76 - $63.23 $35,497 - $46,031	728 Added 6.16%	12,542 $652,000
Q4 2018 Jan 08, 2019	SELL	$48.76 - $63.23 $8,679 - $11,254	-178 Reduced 1.48%	11,814 $654,000
Q3 2018 Oct 10, 2018	BUY	$55.19 - $62.25 $9,823 - $11,080	178 Added 1.51%	11,992 $744,000
Q1 2018 Apr 10, 2018	BUY	$59.92 - $68.98 $353,947 - $407,464	5,907 Added 100.0%	11,814 $747,000
Q4 2017 Jan 08, 2018	SELL	$59.94 - $65.35 $414,005 - $451,372	-6,907 Reduced 53.9%	5,907 $362,000
Q3 2017 Oct 03, 2017	BUY	$55.23 - $63.74 $707,717 - $816,764	12,814	12,814 $817,000

Others Institutions Holding BMY

# of Institutions

2,499

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $90.7B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Curbstone Financial Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Curbstone Financial Management Corp with notifications on news.

Account

Curbstone Financial Management Corp Bristol Myers Squibb CO Transaction History